Long-acting HIV therapies are becoming an increasingly competitive treatment category. While efficacy remains essential, differentiation is now shifting towards factors such as dosing convenience,...
Although modern medicines have transformed HIV into a manageable long-term condition, taking medication every day can still contribute to stigma and treatment fatigue for...
A research team used directed evolution to develop a bespoke aminotransferase, a type of enzyme, to significantly accelerate the manufacturing process and reduce production...
With the new pill, most participants experienced fewer lipid-related side effects, such as increased cholesterol levels, suggesting an additional potential benefit for those at risk of heart...
Developing an intermittent treatment relieves the need for daily pills and, given that no medicine is needed at home, directly addresses the stigma that...
Currently, the only long-acting PrEP therapies require injection by a healthcare provider, which isn’t always feasible for people. Long-acting, oral PrEP therapies could facilitate...
Lopinavir treatment accelerated chondrocyte degradation and promoted senescence, a process in which cells permanently cease growth and division, thereby contributing to osteoarthritis development.
When orally administered, ART must be taken daily. Some patients find it burdensome to take the medications daily or fear being stigmatized when they...
Gilead Sciences signed licensing agreements with six generic manufacturers to increase access to lenacapavir for HIV prevention. But no, it will still not be...